Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2004 8
2006 2
2007 1
2009 2
2010 2
2011 3
2012 6
2013 1
2014 4
2015 6
2016 2
2017 6
2018 5
2019 4
2020 14
2021 17
2022 17
2023 22
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation.
Wu Y, Zhang C, Liu X, He Z, Shan B, Zeng Q, Zhao Q, Zhu H, Liao H, Cen X, Xu X, Zhang M, Hou T, Wang Z, Yan H, Yang S, Sun Y, Chen Y, Wu R, Xie T, Chen W, Najafov A, Ying S, Xia H. Wu Y, et al. Among authors: zhao q. Nat Commun. 2021 Apr 20;12(1):2346. doi: 10.1038/s41467-021-22467-8. Nat Commun. 2021. PMID: 33879767 Free PMC article.
Prospective therapeutics for intestinal and hepatic fibrosis.
Li X, Yu M, Zhao Q, Yu Y. Li X, et al. Among authors: zhao q. Bioeng Transl Med. 2023 Aug 2;8(6):e10579. doi: 10.1002/btm2.10579. eCollection 2023 Nov. Bioeng Transl Med. 2023. PMID: 38023697 Free PMC article. Review.
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter study.
Zhang Y, Zhou H, Duan M, Gao S, He G, Jing H, Li J, Ma L, Zhu H, Chang C, Du X, Hong M, Li X, Liu Q, Wang W, Xu N, Yang H, Lu B, Yin H, Wu L, Suo S, Zhao Q, Xiao Z, Jin J. Zhang Y, et al. Among authors: zhao q. Am J Hematol. 2023 Oct;98(10):1588-1597. doi: 10.1002/ajh.27033. Epub 2023 Jul 20. Am J Hematol. 2023. PMID: 37470365 Clinical Trial.
RUNX-3-expressing CAR T cells targeting glypican-3 in patients with heavily pretreated advanced hepatocellular carcinoma: a phase I trial.
Fu Q, Zheng Y, Fang W, Zhao Q, Zhao P, Liu L, Zhai Y, Tong Z, Zhang H, Lin M, Zhu X, Wang H, Wang Y, Liu Z, Yuan D, Bao X, Gao W, Dai X, Li Z, Liang T. Fu Q, et al. Among authors: zhao q. EClinicalMedicine. 2023 Aug 30;63:102175. doi: 10.1016/j.eclinm.2023.102175. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37680942 Free PMC article.
Deubiquitination and Stabilization of PD-L1 by USP21.
Yang S, Yan H, Wu Y, Shan B, Zhou D, Liu X, Mao X, Zhou S, Zhao Q, Xia H. Yang S, et al. Among authors: zhao q. Am J Transl Res. 2021 Nov 15;13(11):12763-12774. eCollection 2021. Am J Transl Res. 2021. PMID: 34956491 Free PMC article.
123 results